Legal 500
Log in or register
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR

© 2026 Legalease Ltd. All rights reserved

Registered company in England & Wales No. 02427356 VAT GB 321 5727 22

Registered address: 188 Fleet Street, London, EC4A 2AG

  • Legal 500 Trust Centre
  • Contact Us
  • home
  • Market Intelligence
  • Search

4,269 results found

Use advanced search filters to refine your search

2 filters applied

Advanced search filters

Topics
Countries
Contributor

Start typing to add contributors

Content type
Show options
  • Article

    U.S. Senate Approves Bill to Allow Drug Imports from Canada

    The U.S. Senate has approved a proposal in a spending bill that would allow Americans to bring drugs into the U.S. from Canada if they have a prescription for the drug and if the drug is FDA-approved.
    CanadaFood, Drugs, Healthcare, Life Sciences
    Gowling WLG
    Gowling WLG
  • Article

    Video: How Will The Federal Court's Ruling On Changes To The Patented Medicines Regulations Impact The Pharmaceutical Industry?

    Last week, we provided an overview and analysis of the Federal Court of Canada's review of new amendments to the Patented Medicines Regulations was released.
    CanadaFood, Drugs, Healthcare, Life Sciences
Torys
Torys
  • Article

    A High-Stakes Dose: Supreme Court Of Canada To Weigh In On Patenting Methods Of Medical Treatments

    Attention, pharmaceutical companies and medical practitioners! The Supreme Court of Canada ("SCC") is poised to revisit one of the most consequential issues...
    CanadaIntellectual Property
    Oyen Wiggs Green & Mutala
    Oyen Wiggs Green & Mutala
  • Article

    Aiming For More Patents Can Hurt IP Portfolio Value

    Every year, executives at major companies showcase the number of patents they have filed and/or have been granted.
    CanadaIntellectual Property
    McCarthy Tétrault
    McCarthy Tétrault
  • Article

    Amazon.com’s One-Click Patent Application Allowed In Canada

    Following the Federal Court of Appeal decision reported in our November 2011 Blakes Bulletin, in which the Amazon.com application was remanded to the Canadian Intellectual Property Office (CIPO) for further consideration, we have now heard that the application has been allowed and a patent will issue with method and apparatus claims.
    CanadaIntellectual Property
    Blake, Cassels & Graydon LLP
    Blake, Cassels & Graydon LLP
  • Article

    Amendments To Canadian Intellectual Property Laws By 2017

    A note on the CIPO website says that stakeholders will have the opportunity to comment when the proposed amendments/regulations are pre-published in Canada Gazette, Part 1.
    CanadaIntellectual Property
    Field Law
    Field Law
  • Article

    Amendments To The Patented Medicines Regulations Delayed Six Months, Until July 1, 2022

    Canada's recently appointed Minister of Health, the Honourable Jean-Yves Duclos, just announced the deferral of the coming into force of recent amendments to the Patented Medicines Regulations...
    CanadaIntellectual Property
    Gowling WLG
    Gowling WLG
  • Article

    An American Attorney In Canada (Part 3: Letters Of Request In Patent Litigation)

    A recent Ontario court decision dealt with a foreign letter of request, or "letter rogatory" in a cross-border patent infringement case involving the invention of snowmobile prototypes.
    CanadaIntellectual Property
    Field Law
    Field Law
  • Article

    Avoiding IP Ownership Surprises

    Businesses commonly require their employees and independent contractors to sign agreements assigning ownership of all work product and related intellectual property rights to the business.
    CanadaIntellectual Property
    Borden Ladner Gervais LLP
    Borden Ladner Gervais LLP
  • Article

    Bifurcation Refused Where Magnitude Of Savings Not Proven

    The Federal Court refused bifurcation of a patent proceeding into liability and quantification stages.
    CanadaIntellectual Property
    Seastone IP LLP
    Seastone IP LLP
  • Article

    Brexit's Impact On IP Rights

    The UK's Chartered Institute of Patent Attorneys (CIPA) has released a helpful 12-page summary entitled The Impact of Brexit on Intellectual Property.
    CanadaIntellectual Property
    Field Law
    Field Law
  • Article

    Caliber Communications And Syncro Monitoring Acquired In Cross-Border Transaction By Stealth Monitoring

    On April 13, 2023, Stealth Monitoring ("Stealth") announced that it had acquired Caliber Communications and Syncro Monitoring (collectively "Caliber").
    CanadaIntellectual Property
    Gowling WLG
    Gowling WLG
  • Article

    Canada's Federal Court Of Appeal Affirms Invalidity Of Idenix Patent For Insufficient Disclosure

    In their decision reported as 2017 FCA 161, the Federal Court of Appeal says s. 27(3) of the Patent Act requires the patent to disclose both the invention, and how to make the invention.
    CanadaIntellectual Property
    McCarthy Tétrault
    McCarthy Tétrault
  • Article

    Canada Patented Medicines: Federal Court Of Appeal Confirms Mootness Of Innovator Appeals After Generic Marketing Authorization Is Granted

    "Asking a court to prohibit a notice of compliance after it has issued is like asking someone to close the barn door after the horses have escaped."
    CanadaIntellectual Property
    McCarthy Tétrault
    McCarthy Tétrault
  • Article

    Canadian Appeal Court Itching To Consider Patented Medical Treatments

    The Canadian Federal Court of Appeal has recently indicated its interest in revisiting patentability of methods of medical treatment in future in a case where the issue is squarely raised.
    CanadaIntellectual Property
    Smart & Biggar
    Smart & Biggar
  • Article

    Canadian Government Tightens Funding For Certain Research Grants

    As reported by Reuters, Canadian authorities have reportedly announced new restrictions on research grants, with the goal of blocking funding to projects with researchers affiliated...
    CanadaIntellectual Property
    Goodmans LLP
    Goodmans LLP
  • Article

    Canadian Intellectual Property Office (CIPO): Fee Increase

    CIPO has announced an increase in their fees as of January 1, 2024. Their current fees will be increased by at least 25%.
    CanadaIntellectual Property
    Lavery
    Lavery
  • Article

    Canadian Parliament Passes Legislation Implementing The USMCA

    Bill C-4, entitled An Act to implement the Agreement between Canada, the United States of America and the United Mexican States (i.e. the USMCA),...
    CanadaIntellectual Property
    Smart & Biggar
    Smart & Biggar
  • Article

    Certificates Of Supplementary Protection – Transitional Period Ending On September 21, 2018

    Patentees take note: September 21, 2018 marks the first anniversary of the Certificate of Supplementary Protection (CSP) regime in Canada, and it also marks the end of the transitional period for securing a CSP.
    CanadaIntellectual Property
    Smart & Biggar
    Smart & Biggar
  • Article

    CETA Amendments: Certificates Of Supplementary Protection (CSP) Now Available; End Of Dual Litigation

    Following pre-publication on July 15, and flowing from its commitments under CETA, the Certificates of Supplementary Protection Regulations and the Regulations Amending the Patented Medicines...
    CanadaIntellectual Property
    Smart & Biggar
    Smart & Biggar
  • Showing 301–320 of 4269 results

    PreviousNext
    Legal Intelligence Newsletters: sign up for the latest legal and regulatory news on your chosen topics